Android Auto is a must-have driving companion for Android users on the open road. Google's answer to Apple CarPlay can take all the important,car friendly features from your phone and add it to ...

We have the 6-letter answer for Auto-injector brand crossword clue, last seen in the Daily Commuter Crossword January 25, 2025 puzzle. Let us help you solve the crossword clue that has you stumped so ...

Meridian Medical Technologies, a unit of CDMO Kindeva, snared a $129 million contract to supply the United States with the chemical nerve agent antidote autoinjector DuoDote. The FDA-approved ...

Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants, approved after a priority FDA review. Clinical trials showed esketamine's rapid efficacy, with 22. ...

If approved, the injectable version would come packaged in an autoinjector device that allows a person to administer a shot themselves, rather than rely on a healthcare provider. The injection process ...

The product will benefit from Aktiv’s proprietary PenPal gas-driven autoinjector platform including ultra high-performance reliability and unique capabilities to accommodate any standard glass ...

The FDA has accepted Eisai and Biogen’s biologics license application for a subcutaneous autoinjector weekly maintenance dose of Leqembi for patients with mild cognitive impairment or mild ...

While Los Angeles County continues to grapple with a deadly outbreak of wildfires, a new blaze broke out in neighboring Ventura County Monday night. The Auto Fire has burned nearly 61 acres in ...

On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) for lecanemab-irmb (Leqembi) subcutaneous autoinjector (SC-AI ...

FDA sets August 31, 2025, as the action date for Eisai and Biogen's Leqembi subcutaneous autoinjector application. Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly ...

If LEQEMBI subcutaneous maintenance dosing is approved by the FDA, LEQEMBI will be the only treatment for AD that can be administered subcutaneously at home using an autoinjector (AI). The ...